The enzyme lysyl oxidase functions as a suppressor of the phenotypic expression of the ras oncogene. NIH 3T3 mouse cells transformed by LTR-c-H-ras expressed very low levels of lysyl oxidase; expression was restored after interferon beta-mediated reversion. Revertants were retransformed by a lysyl oxidase antisense expression construct; the original transformed cells were reverted after transfection with a lysyl oxidase sense expression construct. Lysyl oxidase transcriptional regulatory sequences will be defined to investigate how the gene is switched off during ras transformation, and how reversion with interferon leads to the restoration of expression. Since demethylation of revertants caused retransformation and loss of lysyl oxidase expression, the control region may require methylation for activity. Positive and/or negative regulatory proteins that bind to the transcriptional regulatory control sequences, perhaps induced by either interferon or ras, will be identified and studied. The possible coordinate regulation of lysyl oxidase, collagen structural genes, and enzymes involved in collagen synthesis following ras transformation and reversion will be investigated. Lysyl oxidase expression in cell lines transformed by oncogenes other than ras will also be studied to reveal any similarities in method of action or interrelationships among ras and other oncogenes. If a relationship exists between lysyl oxidase activity and normal cell growth and behavior, understanding the regulatory mechanisms of this gene may provide opportunities for therapy: drugs that modify lysyl oxidase expression can be identified, and possibly in the future, gene replacement therapy could be considered. Cell lines of human cancers that arise from cells that produce collagen or elastin and lysyl oxidase will be examined for alterations in lysyl oxidase message expression and enzyme activity as well as collagen or elastin levels. If lysyl oxidase gene expression is decreased in any of these human cancers, expression experiments employing the human lysyl oxidase gene will be performed to attempt reversion. Lysyl oxidase has also been localized to some types of epithelia cells. Tumors arising from these tissues will be examined for any changes in lysyl oxidase expression. Normal tissue and cell lines derived from tumors of tissues that show a high incidence of mutation in the ras oncogene will also be examined to determine if there is a correlation between lysyl oxidase expression and transformation similar to that seen in the mouse fibroblast system. The relationship between immature collagen and elastin in cell matrix and possible changes in the binding/activity of growth-promoting or -controlling factors will also be studied.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA037351-12S1
Application #
6024372
Study Section
Pathology B Study Section (PTHB)
Program Officer
Spalholz, Barbara A
Project Start
1984-12-01
Project End
1999-06-30
Budget Start
1999-04-01
Budget End
1999-06-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20817
Contente, Sara; Attard, Frank A; Friedman, Robert M (2006) Identification of proteins immunologically related to interferon regulatory factor-1 that bind with interferon regulatory factor element. J Infect Dis 194 Suppl 1:S27-32
Contente, Sara; Attard, Frank A; Yeh, Tze-Jou Annie et al. (2003) Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. J Interferon Cytokine Res 23:639-47
Contente, S; Kenyon, K; Sriraman, P et al. (1999) Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene. Mol Cell Biochem 194:79-91
Friedman, R M; Yeh, A; Gutman, P et al. (1997) Reversion by deletion of transforming oncogene following interferon-beta and retinoic acid treatment. J Interferon Cytokine Res 17:647-51
Mello, M L; Contente, S; Vidal, B C et al. (1995) Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis. Exp Cell Res 220:374-82
Kenyon, K; Modi, W S; Contente, S et al. (1993) A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25. J Biol Chem 268:18435-7
Contente, S; Csiszar, K; Kenyon, K et al. (1993) Structure of the mouse lysyl oxidase gene. Genomics 16:395-400
Mock, B A; Contente, S; Kenyon, K et al. (1992) The gene for lysyl oxidase maps to mouse chromosome 18. Genomics 14:822-3
Friedman, R M; Yeh, A; Tang, W (1992) Post-transcriptional regulation by interferon-alpha of epsilon-globin production in human erythroleukemia K-562 cells. J Interferon Res 12:311-6
Kenyon, K; Contente, S; Trackman, P C et al. (1991) Lysyl oxidase and rrg messenger RNA. Science 253:802

Showing the most recent 10 out of 15 publications